Reconsidering the Polypill for Management of Cardiovascular Risk Factors in Underserved Patients.

Macaulay, Tracy E; Sheridan, Erica; Ward, Sara

Macaulay, Tracy E; Sheridan, Erica; Ward, Sara.

Affiliation

Macaulay TE; Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, 789 S. Limestone Street, TODD 223, Lexington, KY, 40536, USA. Tracy.macaulay@uky.edu.
Sheridan E; Cardiology Clinical Pharmacist, ProMedica Toledo Hospital/Russell J. Ebeid Children's Hospital, Toledo, OH, USA.
Ward S; Cardiovascular Clinical Pharmacist - Heart Failure, UofL Health-Jewish Hospital, Louisville, KY, USA.

Curr Cardiol Rep ; 23(3): 19, 2021 02 17.

Article in En | MEDLINE | ID: mdl-33598864

Subject(s)

Cardiovascular Diseases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Amlodipine; Antihypertensive Agents/therapeutic use; Cardiovascular Diseases/prevention & control; Drug Combinations; Heart Disease Risk Factors; Humans; Losartan; Risk Factors; Vulnerable Populations

Key words

Cardiovascular disease; Hypertension; Polypill; Population health; Risk modification; Social determinants of health; Underserved

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Cardiovascular Diseases / Hydroxymethylglutaryl-CoA Reductase Inhibitors Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Year: 2021 Type: Article

Fulltext

XML

PubMed Links

Search on Google